ARCHIVES

Also in this 8-page issue: John Montgomery, a founder of BioCryst Pharmaceuticals and a former member of the President’s Cancer Panel, dead.

This article is from The Cancer Letter archive.

Vol. 30 No. 27 | July 2, 2004

Download PDF Visit The Full Archive

Related Articles

In Brief: NIH AIDS William Paul To Step down; Aldige to Lead NCCR; Rimer Joins NCI

October 10, 1997

2018 State of Cancer Care in America

February 3, 2022

Garb Denies He, Panel Said Contract Should Be Primary Funding Mechanism

March 17, 1978

Cancer Survival Now May Be Well Over 50 Percent, ACS President Says; Cigarette Consumption Drops

April 6, 1984

Appropriators Project 1.2% Increase for NIH, Due to Budget Plan

June 20, 1997

FDA Approves Femara As First-Line Treatment For Advanced Breast Cancer.

January 26, 2001